Drugs News and Research

RSS

Gladstone researchers expand mission to tackle emerging infectious threats

From influenza and COVID-19 to HIV, viruses continue to pose a serious danger to global health.

25 Sep 2025

KFF Health News' 'What the Health?': Public health further politicized under the threat of more firings

In a highly unusual White House news conference this week, President Donald Trump — without evidence — boldly blamed the painkiller Tylenol and a string of childhood vaccines for causing a recent rise in autism.

25 Sep 2025

Discovery of EP2 receptor opens path to pain relief without blocking inflammation

Scientists at the NYU Pain Research Center have identified which receptor in prostaglandins-the hormone-like substance targeted by common painkillers-causes pain but not inflammation.

25 Sep 2025

UPR modulators show promise in treating cancer-related bone disease

Before a chain of amino acids can become an active and useful protein, it must be processed and folded into the appropriate conformation.

25 Sep 2025

Targeting TGF-β signaling as a strategy to treat liver fibrosis

Liver fibrosis, a pathological scarring process resulting from chronic liver injury, represents a significant global health burden due to its potential progression to cirrhosis and hepatocellular carcinoma.

25 Sep 2025

Genetic modification enhances "living drugs" for blood cancers

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, with a "chimeric antigen receptor" (CAR) enables them to specifically recognize and attack cancer cells.

25 Sep 2025

Scientists map step-by-step activation of brain receptors

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, know that even slight changes in their activity level can mean the difference between normal function and serious neurological disorders.

24 Sep 2025

Review shows lecanemab and donanemab slow decline and explains who should get them

The Lancet review synthesises evidence on anti beta amyloid monoclonal antibodies and the wider Alzheimer’s care pathway, weighing efficacy, safety, economics, and health system readiness across disease, patient, and population perspectives.

24 Sep 2025

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.

24 Sep 2025

Researchers identify protein crucial for tick-borne encephalitis virus to infect human cells

Researchers at Karolinska Institutet, together with international colleagues, have identified a protein that is crucial for the TBE virus to infect human cells.

24 Sep 2025

FAU study explores how a new drug may help treat PTSD and its common companions

About 12 million adults in the United States are affected by PTSD, impacting between 4% and 8% of the adult population – and up to 30% of military personnel and veterans.

24 Sep 2025

Scientists show for the first time how fibroblasts go 'rogue' in different diseases

Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go 'rogue' in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease.

24 Sep 2025

Groundbreaking discovery could transform leishmaniasis treatment

Leishmaniasis, a neglected tropical disease prevalent across 90 countries, affects approximately 12 million people worldwide, with 350 million more at risk of infection.

24 Sep 2025

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Obstetricians have long advised their pregnant patients that Tylenol is the safest option to reduce fever or pain. President Donald Trump stood before a national audience on Sept. 22 and contradicted that.

24 Sep 2025

Research shows different EML4-ALK variants drive lung cancer aggressiveness

About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK.

23 Sep 2025

NIH funds USC team to develop a selective Alzheimer’s drug for APOE4 carriers

Backed by the combined expertise of three USC schools, scientists are developing a new drug aimed at a previously unexplored biological target in Alzheimer's disease, aided by an $8 million grant from the National Institutes of Health.

23 Sep 2025

Senescent cell subtypes do not respond equally to treatment, study shows

A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled "Senescent cell heterogeneity and responses to senolytic treatment are related to cell cycle status during senescence induction."

23 Sep 2025

Experts call for coordinated global action to make the most of Alzheimer’s treatments

The approval of new antibody medications for Alzheimer's disease – lecanemab and donanemab – and diagnostic tests in the blood mark the beginning of a new era in Alzheimer's disease diagnosis and treatment.

23 Sep 2025

A single drug stabilizes nearly all mutations of key kidney protein

A study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilize nearly all mutated versions of a human protein, regardless of where the mutation is in the sequence.

23 Sep 2025

Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity

Chong Hyun Shin, a research associate professor in the Institute for Biomedical Sciences at Georgia State University, has received a $25,000 grant to develop mechanisms for treating obesity and obesity-related metabolic dysfunctions.

23 Sep 2025

Previous
1
...
93
94
95
96
97
98
99
...
3024
Next

Drugs News and Research

Gladstone researchers expand mission to tackle emerging infectious threats

KFF Health News' 'What the Health?': Public health further politicized under the threat of more firings

Discovery of EP2 receptor opens path to pain relief without blocking inflammation

UPR modulators show promise in treating cancer-related bone disease

Targeting TGF-β signaling as a strategy to treat liver fibrosis

Genetic modification enhances "living drugs" for blood cancers

Scientists map step-by-step activation of brain receptors

Review shows lecanemab and donanemab slow decline and explains who should get them

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

Researchers identify protein crucial for tick-borne encephalitis virus to infect human cells

FAU study explores how a new drug may help treat PTSD and its common companions

Scientists show for the first time how fibroblasts go 'rogue' in different diseases

Groundbreaking discovery could transform leishmaniasis treatment

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Research shows different EML4-ALK variants drive lung cancer aggressiveness

NIH funds USC team to develop a selective Alzheimer’s drug for APOE4 carriers

Senescent cell subtypes do not respond equally to treatment, study shows

Experts call for coordinated global action to make the most of Alzheimer’s treatments

A single drug stabilizes nearly all mutations of key kidney protein

Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News